Research
Early trial results suggest potential new treatment for stiff person syndrome
The Brief
- A multicenter clinical trial evaluated CAR-T cell therapy for stiff person syndrome, a rare autoimmune neurologic disorder.
- The trial has produced promising early results, according to Medical Xpress reporting on 2026-11-09.
- The source describes the findings as early and does not report details on patient numbers, outcomes or safety.
Why it matters
It is an early signal that CAR-T cell therapy, already used in some blood cancers, is being tested in a rare autoimmune neurological disease, which could inform future research directions.
Who’s affected
- patients and clinicians working with stiff person syndrome
- researchers in autoimmune neurology and cell therapy
- #car-t
- #stiff-person-syndrome
- #autoimmune
- #neurology
- #clinical-trial
A multicenter clinical trial evaluating chimeric antigen receptor-T cell therapy (CAR-T cell therapy) for stiff person syndrome (SPS), a rare autoimmune neurologic disorder, has produced promising early results.
Timeline
Medical Xpress reports early multicenter trial results for CAR-T therapy in stiff person syndrome
Medical Xpress - latest medical and health news stories
Early trial results suggest potential new treatment for stiff person syndrome